Bayesian Capital Management, LP Compass Pathways PLC Transaction History
Bayesian Capital Management, LP
- $582 Million
- Q1 2025
A detailed history of Bayesian Capital Management, LP transactions in Compass Pathways PLC stock. As of the latest transaction made, Bayesian Capital Management, LP holds 15,100 shares of CMPS stock, worth $128,953. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,100Holding current value
$128,953% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CMPS
# of Institutions
156Shares Held
52.6MCall Options Held
349KPut Options Held
258K-
Deep Track Capital, LP Greenwich, CT8.86MShares$75.7 Million2.65% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$47.3 Million0.77% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA3.86MShares$32.9 Million7.94% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.36MShares$28.7 Million7.79% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.83MShares$24.2 Million1.09% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...